A real-world study finds cardiovascular and survival benefits from dual therapy in patients with type 2 diabetes.

CHARLIE Sadler had never felt so low in his life – weighing 34 stone and stuck in a painful cycle of comfort eating, he saw ...

A YOUNG woman has revealed that she lost five and a half stone after using fat jabs for nine months. Bethany Diana, 27, ...

Continuous glucose monitoring with low-glucose alerts shows potential for reducing hypoglycemia risk in insulin-treated ...

While ChatGPT consistently produced responses that were factually correct in many cases, experts unanimously agreed that the ...

Vertex plans to submit regulatory filings seeking approval for zimislecel in type 1 diabetes in 2026. However, it is likely to stop further development of VX-264.

Yesterday, on March 31, the Data and Safety Management Board (DSMB) for Sernova’s Phase 1/2 clinical trial, conducted a scheduled annual data review. The DSMB has sanctioned the enrollment of the ...

Use of cutting-edge weight-loss drugs like Ozempic and Zepbound has increased dramatically among people with type 1 diabetes, raising safety concerns among experts, a new study says.

Key Takeaways More people with type 1 diabetes are severely obese and using GLP-1 drugs for weight lossExperts are concerned ...